Skip to main content
. Author manuscript; available in PMC: 2015 Aug 22.
Published in final edited form as: Int J Gynecol Cancer. 2014 May;24(4):670–675. doi: 10.1097/IGC.0000000000000109

Figure 2.

Figure 2

Disease-specific and progression-free survival stratified by obesity status. There were no significant differences in DSS (8.4 versus 12.2 years; p=0.5) and PFS (1.5 versus 2.6 years; p=0.2) in obese and non-obese women with LGSC.